Insights and Implications of the VA Rheumatoid Arthritis Registry

Ted R Mikuls¹, Andreas Reimold¹, Gail S Kerr¹, Grant W Cannon¹

Affiliations

Affiliation

¹ is a staff rheumatologist and research scientist at the VA Nebraska Western-Iowa Health Care System and the Umbach Professor of Rheumatology at the University of Nebraska Medical Center, both in Omaha. is chief of the Rheumatology Section at the Dallas VAMC and associate professor at the University of Texas Southwestern Medical Center, both in Dallas. is chief of the Division of Rheumatology at the Washington DC VAMC and professor of medicine at Georgetown University, both in Washington, DC. is associate chief of staff at the George E. Wahlen VAMC and professor of medicine in the Division of Rheumatology at the University of Utah, both in Salt Lake City.

PMID: 30766061
PMCID: PMC6363303

Review

Insights and Implications of the VA Rheumatoid Arthritis Registry

Ted R Mikuls et al. Fed Pract. 2015 May.

. 2015 May;32(5):24-29.

Authors

Ted R Mikuls¹, Andreas Reimold¹, Gail S Kerr¹, Grant W Cannon¹

Affiliation

¹ is a staff rheumatologist and research scientist at the VA Nebraska Western-Iowa Health Care System and the Umbach Professor of Rheumatology at the University of Nebraska Medical Center, both in Omaha. is chief of the Rheumatology Section at the Dallas VAMC and associate professor at the University of Texas Southwestern Medical Center, both in Dallas. is chief of the Division of Rheumatology at the Washington DC VAMC and professor of medicine at Georgetown University, both in Washington, DC. is associate chief of staff at the George E. Wahlen VAMC and professor of medicine in the Division of Rheumatology at the University of Utah, both in Salt Lake City.

PMID: 30766061
PMCID: PMC6363303

Abstract

The VA Rheumatoid Arthritis Registry addresses the underrepresentation of veterans in rheumatoid arthritis research, serving as a repository that links banked serum, plasma, and DNA samples with an array of patient-level information.

PubMed Disclaimer

Conflict of interest statement

Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.

Cited by

Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US Veterans.
Aripova N, Thiele GM, Duryee MJ, Hunter CD, Yang Y, Roul P, Ascherman DP, Matson SM, Kunkel G, Cannon GW, Wysham KD, Kerr GS, Monach PA, Baker JF, Poole JA, Mikuls TR, England BR. Aripova N, et al. Arthritis Rheumatol. 2024 Sep;76(9):1353-1363. doi: 10.1002/art.42916. Epub 2024 Jun 8. Arthritis Rheumatol. 2024. PMID: 38766737
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease.
Wheeler AM, Baker JF, Poole JA, Ascherman DP, Yang Y, Kerr GS, Reimold A, Kunkel G, Cannon GW, Wysham KD, Singh N, Lazaro D, Monach P, Bridges SL Jr, Mikuls TR, England BR. Wheeler AM, et al. Semin Arthritis Rheum. 2022 Dec;57:152098. doi: 10.1016/j.semarthrit.2022.152098. Epub 2022 Sep 17. Semin Arthritis Rheum. 2022. PMID: 36155967 Free PMC article.
Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort.
Luedders BA, Wheeler AM, Ascherman DP, Baker JF, Duryee MJ, Yang Y, Roul P, Wysham KD, Monach P, Reimold A, Kerr GS, Kunkel G, Cannon GW, Poole JA, Thiele GM, Mikuls TR, England BR. Luedders BA, et al. Arthritis Rheumatol. 2024 Jul;76(7):1013-1022. doi: 10.1002/art.42812. Epub 2024 Feb 15. Arthritis Rheumatol. 2024. PMID: 38268499 Free PMC article.
Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung disease.
Wheeler AM, Baker JF, Riley T, Yang Y, Roul P, Wysham KD, Cannon GW, Kunkel G, Kerr G, Ascherman DP, Monach P, Reimold A, Poole JA, Merriman TR, Mikuls TR, England BR. Wheeler AM, et al. Rheumatology (Oxford). 2025 Jan 1;64(1):268-275. doi: 10.1093/rheumatology/keae001. Rheumatology (Oxford). 2025. PMID: 38243706 Free PMC article.
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
Johnson TM, Sayles HR, Baker JF, George MD, Roul P, Zheng C, Sauer B, Liao KP, Anderson DR, Mikuls TR, England BR. Johnson TM, et al. Ann Rheum Dis. 2021 Nov;80(11):1385-1392. doi: 10.1136/annrheumdis-2021-220125. Epub 2021 May 28. Ann Rheum Dis. 2021. PMID: 34049859 Free PMC article.

See all "Cited by" articles

References

1. Banerjee S, Compton AP, Hooker RS, et al. Cardiovascular outcomes in male veterans with rheumatoid arthritis. Am J Cardiol. 2008;101(8):1201–1205. - PubMed
1. Weyand CM, Schmidt D, Wagner U, Goronzy JJ. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum. 1998;41(5):817–822. - PubMed
1. Mikuls TR, Fay BT, Michaud K, et al. Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry. Rheumatol (Oxford) 2011;50(1):101–109. - PMC - PubMed
1. Baker JF, Billig E, Cannon GW, Caplan L, Majithia V, Mikuls TR. Weight loss and risk of death in rheumatoid arthritis [abstract 1391] Arthritis Rheumatol. 2014;66(suppl 10):S613–S614. - PMC - PubMed
1. Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359(9313):1173–1177. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Insights and Implications of the VA Rheumatoid Arthritis Registry

Affiliation

Insights and Implications of the VA Rheumatoid Arthritis Registry

Authors

Affiliation

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources